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ABSTRACT 
In this study, we modulated the anti-cancer efficacy of 5-Fluorouracil (5-FU) using a carrier 
system with enhanced targeting efficacy towards folate receptors (FRs) expressing malignant 
tissues. The 5-FU drug was loaded onto Mn-ZnS quantum dots (QDs) encapsulated with 
chitosan (CS) biopolymer and conjugated with folic acid (FA) based on a simple wet 
chemical method. The formation of 5-FU drug loaded composite was confirmed using 
Fourier transform infrared spectroscopy (FTIR), thermo gravimetric analysis (TGA) and 
differential scanning calorimetry (DSC). Furthermore, the in vivo biodistribution and tumor 
targeting specificity of the 5-FU@FACS-Mn:ZnS in the tumor-bearing mice was conducted 
based on the Zn2+ tissue bioaccumulation using inductively coupled plasma (ICP) 
spectroscopy. In addition to the characterization, the in vitro release profile of 5-FU from the 
conjugates investigated under diffusion controlled method demonstrated a controlled release 
behaviour as compared against the release behaviour of free 5-FU drug. The as-synthesized 
5-FU@FACS-Mn:ZnS nanoparticle (NP) systemically induced higher level of apoptosis in 
breast cancer cells in vitro as compared to cells treated with free 5-FU drug following both 
cell cycle and annexin assays, respectively. Also, the in vivo toxicity assessment of the 5-
FU@FACS-Mn:ZnS NPs as compared to the control did not cause any significant increase in 
the activities of the liver and kidney function biomarkers, malondialdehyde (MDA) and nitric 
oxide (NO) levels. However, based on the FA-FRs chemistry, the 5-FU@FACS-Mn:ZnS NPs 
specifically accumulated in the tumor of the tumor-bearing mice and thus contributed to the 
smaller tumor size and less event of metastasis was observed in the lungs when compared to 
the tumor-bearing mice groups treated with the free 5-FU drug. In summary, the results 
demonstrated that the 5-FU@FACS-Mn:ZnS QDs exhibits selective anti-tumor effect in 
MDA-MB231 breast cancer cells in vitro and 4TI breast cancer cells in vivo, providing a 
blueprint for improving the 5-FU efficacy and tumor targeting specificity with limited 
systemic toxicity. 
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